- Asked by: Alexander Burnett, MSP for Aberdeenshire West, Scottish Conservative and Unionist Party
-
Date lodged: Tuesday, 03 November 2026
-
Current Status:
Answered by Angela Constance on 16 November 2026
To ask the Scottish Government what assessment it has made of the potential for the Insch Hospital site to support integrated community health and social care provision, including diagnostic, rehabilitation, preventative and palliative care services.
Answer
I refer the member to the answer to question S7W-04723 on 16 November 2026. Furthermore, we understand that NHS Grampian and Aberdeenshire HSCP identified significant infrastructure challenges and safety considerations with the existing building. Concerns were also raised by the Scottish Fire and Rescue Service regarding the safe emergency evacuation from the building.
All answers to written Parliamentary Questions are available on the Parliament's website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers.
- Asked by: Katy Clark, MSP for West Scotland, Scottish Labour
-
Date lodged: Tuesday, 03 November 2026
-
Current Status:
Answered by Angela Constance on 16 November 2026
To ask the Scottish Government for what reason some women with ovarian cancer are offered additional cycles of treatment prior to surgery, what assessment it has made of the impact of this approach on patient outcomes, and how any identified challenges are being addressed.
Answer
Decisions regarding the sequencing of ovarian cancer treatment, including whether surgery takes place before or after chemotherapy, are clinical matters for multidisciplinary teams within NHS Boards. These decisions are based on the individual circumstances of each patient and the available clinical evidence.
The Scottish Government does not direct individual treatment decisions. However, the Cancer Quality Performance Indicator programme supports monitoring of ovarian cancer services across Scotland and helps identify opportunities to improve the quality, consistency and outcomes of care.
- Asked by: Katy Clark, MSP for West Scotland, Scottish Labour
-
Date lodged: Tuesday, 03 November 2026
-
Current Status:
Answered by Angela Constance on 16 November 2026
To ask the Scottish Government what action it is taking to ensure that women with ovarian cancer who are assessed as inoperable, or whose surgery is considered not to be possible within services in the West of Scotland, are able to access a second opinion and expertise, particularly when there are differing clinical opinions regarding whether surgery is appropriate.
Answer
Decisions regarding whether surgery is appropriate for women with ovarian cancer are clinical matters for multidisciplinary teams within NHS Boards, based on individual clinical circumstances and the available evidence.
The NHS Scotland Patient Charter makes clear that patients have the right to ask for a second opinion. NHS Boards are responsible for ensuring appropriate arrangements are in place to support access to further specialist advice where clinically appropriate.
- Asked by: Craig Hoy, MSP for Dumfriesshire, Scottish Conservative and Unionist Party
-
Date lodged: Tuesday, 03 November 2026
-
Current Status:
Answered by Jenny Gilruth on 16 November 2026
To ask the Scottish Government how much it has spent on the development and delivery of its bond programme since 1 April 2026, broken down by (a) banking and bookrunner fees, (b) legal advice, (c) credit rating costs and (d) other external advice and costs.
Answer
Total external costs in 2025-26 relating to the Scottish Government Bond Programme, including associated credit rating activity, were £430,000, excluding VAT, set against an original budget allocation of £1 million for 2025-26.
The Scottish Government has a total programme budget of £2.1 million for 2026-27. Costs are forecast to remain within this budget. A detailed breakdown of costs cannot be provided as requested at this time due to commercial sensitivities.
- Asked by: Craig Hoy, MSP for Dumfriesshire, Scottish Conservative and Unionist Party
-
Date lodged: Tuesday, 03 November 2026
-
Current Status:
Answered by Jenny Gilruth on 16 November 2026
To ask the Scottish Government, regarding the £576 million of savings identified in Annex B, Portfolio Efficiency and Reform Plans, of its Scottish Spending Review 2026, how much had been realised as at 30 September 2026, broken down by portfolio.
Answer
As set out in the Scottish Spending Review published in January 2026, we will update and publish revised plans as further progress is made to deliver the Fiscal Sustainability Delivery Plan targets, which extend to 2029-30.
- Asked by: Adam Harley, MSP for Strathkelvin and Bearsden, Scottish Liberal Democrats
-
Date lodged: Tuesday, 03 November 2026
-
Current Status:
Answered by Angela Constance on 16 November 2026
To ask the Scottish Government what consideration it has given to providing interim access arrangement for Skyclarys for eligible patients living with Friedreich's ataxia in Scotland while assessment of the treatment is ongoing.
Answer
I refer the member to the answer to S7W-04713 on 16 November 2026. All answers to written Parliamentary Questions are available on the Parliament's website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers.
- Asked by: Alexander Burnett, MSP for Aberdeenshire West, Scottish Conservative and Unionist Party
-
Date lodged: Tuesday, 03 November 2026
-
Current Status:
Answered by Angela Constance on 16 November 2026
To ask the Scottish Government what information it holds regarding the progress made by NHS Grampian and Aberdeenshire Health and Social Care Partnership in exploring the creation of a wellbeing hub and additional clinical space within the Insch Hospital site, as agreed by the Integration Joint Board in July 2025.
Answer
I refer the member to the answer to question S7W-04723 on 16 November 2026. All answers to written Parliamentary Questions are available on the Parliament's website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers.
- Asked by: Alexander Burnett, MSP for Aberdeenshire West, Scottish Conservative and Unionist Party
-
Date lodged: Tuesday, 03 November 2026
-
Current Status:
Answered by Angela Constance on 16 November 2026
To ask the Scottish Government what discussions it has had with NHS Grampian regarding the future disposal of the Insch Hospital site, and what opportunities exist for the community's proposed alternative model of care to be considered before any disposal is completed.
Answer
Decisions regarding the planning and delivery of local NHS services are matters for NHS Boards and local partners exercising their statutory responsibilities in line with the Public Bodies (Joint Working) (Scotland) Act 2014. Decisions regarding the future use or disposal of the site are matters for NHS Grampian.
- Asked by: Adam Harley, MSP for Strathkelvin and Bearsden, Scottish Liberal Democrats
-
Date lodged: Tuesday, 03 November 2026
-
Current Status:
Answered by Angela Constance on 16 November 2026
To ask the Scottish Government who is responsible for decisions regarding access to medicines for rare diseases, including Skyclarys for people living with Friedreich's ataxia, and what timescale it anticipates for eligible patients in Scotland to be able to access the treatment.
Answer
In Scotland, the Scottish Medicines Consortium (SMC) appraises the clinical and cost-effectiveness of newly licensed medicines for routine use in the NHS in Scotland. The SMC appraisal is undertaken independently of Scottish Ministers. Following a ‘not recommended’ decision, a pharmaceutical company may resubmit the medicine to the SMC. This may involve offering the NHS a lower price for the medicine and/or providing additional evidence to support its clinical and cost effectiveness.
The decision on whether to resubmit omaveloxolone (Skyclarys®) to the SMC, and the timing of that resubmission, is entirely one for Biogen to make.
Ultimately, decisions to prescribe a medicine and which medicine to prescribe are made through shared decision-making between individuals, families and the clinicians in charge of care having considered their clinical condition, their safety, and any relevant clinical guidance.
- Asked by: Monica Lennon, MSP for Glasgow, Scottish Labour
-
Date lodged: Tuesday, 03 November 2026
-
Current Status:
Answered by Jenny Gilruth on 16 November 2026
To ask the Scottish Government, further to the answer to question S7W-04098 by Jenny Gilruth on 29 October 2026, whether it will provide details of the regional summits that are planned for November 2026, including dates, locations, anticipated attendees and arrangements for public participation.
Answer
The Scottish Government is holding a series of regional dialogue events in November 2026 as part of its Local Governance Reform Programme.
Events are currently scheduled to take place in:
- Hamilton - 11 November
- Perth - 12 November
- Dunfermline - 17 November
- Aberdeen - 23 November
These events will bring together elected members, local government representatives, public sector partners, community organisations and third sector stakeholders to discuss the future of local governance in Scotland and the reforms needed to improve outcomes for people and communities.
The events will involve facilitated discussions and workshops focused on the challenges facing Scotland, the outcomes reform should seek to achieve, and the distribution of responsibilities across national, regional, local and community levels.